Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Cybersecurity Where You Are (audio)

Episode 138: The Use of GenAI to Refine Your TTX Development

04 Jun 2025

Description

In episode 138 of Cybersecurity Where You Are, Sean Atkinson is joined by Timothy Davis, Lead Cyber Threat Intelligence (CTI) Analyst at the Center for Internet Security®(CIS®). Together, they discuss how organizations can use Generative Artificial Intelligence (GenAI) to refine how they develop Tabletop Exercises (TTXs). Here are some highlights from our episode:01:49. Why TTXs function as a "blue sky" opportunity for crisis management and preparedness04:33. A quick recap of how GenAI stands apart from traditional AI06:19. The direct relationship between input and output when measuring GenAI content quality07:36. TTXs as a use case for GenAI to help the "cyber-underserved"10:14. How GenAI can quickly customize TTXs for different organizations and threat models13:56. The use of GenAI to improve TTX facilitation, regularity, and cost17:22. GenAI as an inspiration to act on the findings of a simulation18:26. Risks and ethical concerns to keep in mind for GenAI-enhanced TTX development24:46. Where humans can still play a part in augmented exercises30:08. Closing thoughts about the future of GenAIResourcesLeveraging Generative Artificial Intelligence for Tabletop Exercise DevelopmentEpisode 134: How GenAI Lowers Bar for Cyber Threat ActorsEpisode 89: How Threat Actors Are Using GenAI as an EnablerDeepSeek: A New Player in the Global AI RaceMulti-State Information Sharing and Analysis Center®If you have some feedback or an idea for an upcoming episode of Cybersecurity Where You Are, let us know by emailing [email protected].

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.